单核酸多态性rs6592645通过调节LRRC32表达方式,使喘风险增加
Yi-Kun Li1, Hong-Yan Wang1, Ying Chen1
1College of Life Sciences, Shaanxi Normal University, Xi'an, Shaanxi 710119, P.R. China.
Experimental and therapeutic medicine
|August 24, 2023
概括
喘易感性的遗传变异与SNP rs6592645有关,该SNP调节了LRRC32的表达. 这一发现澄清了喘背后的机制.
科学领域:
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 喘表现出遗传倾向,SNP rs7130588之前通过GWAS与疾病有关.
- SNP rs6592645与rs7130588存在连接不平衡,这表明它也可能与喘有关.
- 确切的因果性SNP及其在喘病原性中的机制仍然不清楚.
研究的目的:
- 为了确定与喘相关的因果单核酸多态性 (SNP).
- 阐明鉴定SNP对基因表达的调控机制.
- 研究LRRC32在喘发展中的作用.
主要方法:
- 双露西法酶试验被用来评估SNP的功能影响.
- 染色体构造捕获 (3C) 确定了调节元素和基因促进体之间的相互作用.
- 在肺组织中量化基因表达,染色体免疫沉 (ChIP) 确定了蛋白质-DNA相互作用.
主要成果:
- SNP rs6592645,而不是rs7130588,在光酶试验中显示出异位基因特异性调节活性.
- 含有rs6592645的增强体区域与LRRC32.3的促进体相互作用.
- 在喘患者中,LRRC32的表达升高,并且依赖基因型,TCF3与rs6592645区域结合.
结论:
- SNP rs6592645可能是影响喘易感性的因果变体.
- rs6592645调节了LRRC32的表达,这使得该基因与喘病因产生有关.
- 与rs6592645的TCF3相互作用为喘遗传风险的分子机制提供了洞察力.
更多相关视频
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
484
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
33.8K
相关概念视频
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma-I: Introduction
2.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K
Asthma: Pathogenesis and Management
443
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
443
Antiasthma Drugs: Leukotriene Modifiers
355
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
355
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Single Nucleotide Polymorphisms-SNPs
15.3K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.3K
